Bone marrow transplantation in pediatric patients with therapy-related myelodysplasia and leukemia

Bone Marrow Transplantation

Volumn 23, Issue 1, 1999, Pages 21-25

  Leahey, A M ^a,b   Friedman, D L ^a   Bunin, N J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHOP   (United States)

Author keywords

Acute myeloid leukemia; Bone marrow transplantation; Pediatric; Therapy related

Indexed keywords

ALKYLATING AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; DNA TOPOISOMERASE INHIBITOR;

ADOLESCENT; ARTICLE; BLADDER DISEASE; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CARDIOTOXICITY; CHILD; CLINICAL ARTICLE; DUODENUM CARCINOMA; FEMALE; GLIOBLASTOMA; GRAFT VERSUS HOST REACTION; HUMAN; IRRADIATION; LEUKEMIA; LIVER TOXICITY; MALE; MORTALITY; MYELODYSPLASIA; NEPHROTOXICITY; OSTEOSARCOMA; PRIORITY JOURNAL; RECURRENT CANCER; SOLID TUMOR; SUBCONJUNCTIVAL DRUG ADMINISTRATION;

EID: 0032969644     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701517     Document Type: Article

References (29)

1. Pui C-H, Ribeiro RC, Hancock ML et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. New Engl J Med 1991; 325: 1682-1687.
2. Bhatia S, Robison LL, Oberlin O et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. New Engl J Med 1996; 334: 745-751.
3. Smith MA, McCaffrey RP, Karp JE. The secondary leukemias: challenges and research directions. J Natl Cancer Inst 1996; 88: 407-418.
4. Michels SD, McKenna RW, Arthur DC, Brunning RD. Therapy-related leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases. Blood 1985; 65: 1364-1372.
5. Laver JH, Yusuf U, Cantu ES et al. Transient therapy-related myelodysplastic syndrome associated with monsomy 7 and 11q23 translocation. Leukemia 1997; 11: 448-455.
6. Kantarjian HM, Estey EH, Keating MJ. Treatment of therapy-related leukemia and myelodysplastic syndrome. Hematol Oncol Clin North Am 1993; 7: 81-107.
7. Anderson JE, Gooley TA, Schoch G et al. Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy. Blood 1997; 89: 2578-2585.
8. Ballen KK, Gilliland DG, Guinan EC et al. Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia. Bone Marrow Transplant 1997; 20: 737-743.
9. Longmore G, Guinan EC, Weinstein H et al. Bone marrow transplantation for myelodysplasia and secondary acute non-lymphoblastic leukemia. J Clin Oncol 1990; 8: 1707-1714.
10. Sutton L, Leblond V, Le Maignan C et al. Bone marrow transplantation for myelodysplastic syndrome and secondary leukemia: outcome of 86 patients. Bone Marrow Transplant 1991; 7 (Suppl. 2): 39.
11. De Witte T, Zwaan F, Hermans J et al. Allogeneic bone marrow transplantation for secondary leukemia and myelodysplastic syndrome: a survey by the Leukemia Working Party of the European Bone Marrow Transplantation Group (EBMTG). Br J Haematol 1990; 74: 151-155.
12. Sandler ES, Friedman DJ, Mustafa MM et al. Treatment of children with epipodophyllotoxin-induced secondary acute myeloid leukemia. Cancer 1997; 79: 1049-1054.
13. Pui C-H, Relling MV, Rivera GK et al. Epipodophyllotoxin-related acute myeloid leukemia: a study of 35 cases. Leukemia 1995; 9: 1990-1996.
14. Bennett JM, Catovsky D, Daniel MT et al. French-American-British (FAB) Cooperative group: proposals for the classification of the acute leukemias. Br J Haematol 1976; 33: 451-458.
15. Bennett JM, Catovsky D, Daniel MT et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189-199.
16. Wells RJ, Feusner J, Devney R et al. Sequential high-dose cytosine arabinoside L-asparaginase in advanced childhood leukemia. J Clin Oncol 1985; 3: 998-1004.
17. Buckley JD, Lampkin BC, Nesbit ME et al. Remission induction in children with acute non-lymphocytic leukemia using cytosine arabinoside and doxorubicin or daunorubicin: a report from the Children's Cancer Study Group. Med Pediatr Oncol 1989; 17: 382-390.
18. Ash R, Casper J, Chitambar C et al. Successful allogeneic transplantation of T-cell depleted bone marrow from closely HLA-matched donors. New Engl J Med 1990; 322: 485-494.
19. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients from HLA-matched sibling donors. Transplantation 1974; 18: 295-304.
20. Bearman SI, Appelbaum FR, Buckner CD et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 1988; 6: 1562-1568.
21. Kaplan G, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 454-481.
22. Geller RB, Vogelsang GB, Wingard JR et al. Successful marrow transplantation for acute myelocytic leukemia following therapy for Hodgkin's disease. J Clin Oncol 1988; 6: 1558-1561.
23. Gyger M, Perreault C, Boileau J et al. Restoration of normal hematopoiesis by bone marrow ablation and allogeneic marrow transplantation in a case of Hodgkin's disease therapy-related preleukemia. Blood 1983; 61: 1279-1281.
24. Sargur M, Buckner CD, Appelbaum FR et al. Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's disease. J Clin Oncol 1987; 5: 731-734.
25. Le Beau MM, Albain KS, Larson RA et al. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosome no. 5 and 7. J Clin Oncol 1986; 4: 325-345.
26. Felix CA, Hosler MR, Winick NJ et al. ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children. Blood 1995; 85: 3250-3256.
27. Quesnel B, Kantarjian H, Bjergaard JP et al. Therapy-related acute myeloid leukemia with t (8:21), inv (16), and t (8;16): a report on 25 cases and review of the literature. J Clin Oncol 1993; 11: 2370-2379.
28. Curtis RE, Rowlings PA, Deeg JA et al. Solid cancers after bone marrow transplantation. New Engl J Med 1997; 336: 897-904.
29. Miller JS, Arthur DC, Litz CE et al. Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy. Blood 1994; 83: 3780-3786.